Home › Myasthenia Gravis › California › Mountain View
Myasthenia Gravis clinical trials in Mountain View, CA
4 studies for Myasthenia Gravis are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
RecruitingPhase 1
- Stanford Neuroscience Health Center, Palo Alto · 5 mi away
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- Lucile Packard Children's Hospital Stanford, Palo Alto · 5 mi away
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- Stanford University Medical Center, Palo Alto · 5 mi away
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RecruitingPhase 1
- Stanford Hospital, Palo Alto · 5 mi away
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Miami, FL7 studies
- New York City, NY7 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- Boston, MA6 studies
- Washington, DC6 studies
- San Francisco, CA6 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Prostate Cancer15 studies
- Heart Failure15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.